← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Senseion Therapeutics, Inc.
Saint Louis, MO
$6,640,902
Total funding
3
Grants
Funding over time
peak $2.1M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,640,902 · 3
By mechanism
R44$6,640,902 · 3
Investigators at Senseion Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis$1,089,280
R44 · FY2022 · DK
Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes$1,015,058
R44 · FY2025 · HL
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes$993,178
R44 · FY2021 · DK
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes$990,929
R44 · FY2022 · DK
Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes$982,162
R44 · FY2024 · HL
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis$945,785
R44 · FY2021 · DK
Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes$323,485
R44 · FY2023 · HL
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis$301,025
R44 · FY2020 · DK